PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Apr-2023 OWEN MUMFORD WINS DISTINCTION IN RED DOT AWARD (PRODUCT DESIGN 2023) FOR AIDAPTUS® AUTO-INJECTOR OWEN MUMFORD
19-Apr-2023 Readygo Diagnostics and Gemina Laboratories Enter an Assay Development Agreement for the Rapid Detection of Mycobacterium Tuberculosis (MTB) ReadyGo Diagnostics Ltd.
19-Apr-2023 Macomics Presents its ENIGMAC™ Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR Macomics Ltd
19-Apr-2023 Maxion Therapeutics Awarded £2 Million Innovate UK Funding to Develop Ion Channel Antibodies for “Hard-To-Treat" Autoimmune Diseases Maxion Therapeutics
19-Apr-2023 Form 8-K Filed by Rosecliff Acquisition Corp I Spectral MD Holdings, Ltd.
19-Apr-2023 Kromek and Analogic Announce Collaboration Agreement to Develop Next Generation Computed Tomography (CT) Detector Technology Kromek Group plc
19-Apr-2023 Zymeworks Presents New Data From Multiple Preclinical And Clinical Development Programs At The 2023 American Association For Cancer Research Annual Meeting Zymeworks
19-Apr-2023 ALMADEN GENOMICS UPDATES G.NOME PLATFORM WITH JUPYTER NOTEBOOK INTEGRATION Almaden Genomics
19-Apr-2023 Maxion Therapeutics Awarded £2 Million Innovate UK Funding to Develop Ion Channel Antibodies for “Hard-To-Treat" Autoimmune Diseases B3C newswire
19-Apr-2023 Cannovum AG develops cultivation kits for Cannabis Social Clubs Cannovum AG
19-Apr-2023 Biophytis regains compliance with NASDAQ minimum bid price requirement Biophytis
19-Apr-2023 Grünenthal GmbH: Grünenthal announces pricing of €300 million bond Grünenthal GmbH
19-Apr-2023 Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023 Marinomed Biotech AG
19-Apr-2023 PharmaSGP plans dividend distribution of 49.2% after record year in 2022 PharmaSGP Holding SE
18-Apr-2023 Gerresheimer AG: Gerresheimer AG successfully completes EUR 271.6 million capital increase Gerresheimer AG
18-Apr-2023 Gerresheimer AG: Gerresheimer AG issues 3,140,000 million new shares at a placement price of EUR 86.50 per new share Gerresheimer AG
18-Apr-2023 Abivax appoints Michael Ferguson as Chief Commerical Officer ABIVAX
18-Apr-2023 Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares Gerresheimer AG
18-Apr-2023 Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares Gerresheimer AG
18-Apr-2023 Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting Evolva Holding SA